CPG
VCNX icon

Cornerstone Planning Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Cornerstone Planning Group’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$9 – 1198
2023
Q4 		$9 Hold
1
– – ﹤0.01% 950
2023
Q3 		$16 Hold
1
– – ﹤0.01% 1182
2023
Q2 		$71 Buy
+1
New +$83 ﹤0.01% 1549
2022
Q4 		$122 Buy
+1
New +$124 ﹤0.01% 1530

Other funds holding VCNX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cornerstone Planning Group's VCNX Position: Q1 2024 in Review

Cornerstone Planning Group sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 1 share — an estimated $9 sold.

Cornerstone Planning Group first reported a position in VCNX in Q4 2022 and held it in 4 quarters. The position peaked at $122 in Q4 2022. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • Cornerstone Planning Group reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cornerstone Planning Group sold 1 Vaccinex, Inc. Common Stock share in Q1 2024, an estimated $9.
  • Cornerstone Planning Group first reported a position in Vaccinex, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Cornerstone Planning Group's Vaccinex, Inc. Common Stock position peaked at $122 in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Cornerstone Planning Group's 13F filing for Q1 2024, filed 7 May 2024.